The pharmaceuticals company Pfizer invested serious money into its La Jolla shop recently, showing its confidence in the La Jolla/San Diego area for biotech, high-tech learning and business industry.
La Jolla remains the place to be for top-notch biomedicine companies and is noted as the number one bio-medical research hub in the world.
For Pfizer, the $372 million purchase is following years of continued growth and expansion at the research and development campus, including some $150 million improvements in the form of new laboratories and offices.
With the concentration on research the campus’ benefits greatly from a locale close to the educational areas of UCSD. It’s a very collaborative community, It’s not competitive. People get together work together. Everybody’s trying to advance the sciences. With a lot of Technology support as well as the skilled research personnel.
Students will have opportunity to interact with their laboratories & graduates might possibly end up working there.
La Jolla’s growth as a center of excellence for biotech and pharmaceuticals working together between Burnham Institute, Pharma and biotech research institutes and even the venture capital community benefits by all of this.
With a very strong job market and excellent infrastructure that has made this such a popular area for high-tech industry. There are so many benefits to all the parties in collaborating, improving our technology capabilities by tapping into all of these other resources.
Regarding Pfizer’s purchase, certainly real estate investments aren’t a bad way to go here in San Diego. They had wanted to own it & have been trying to get their hands on the deed for the land for quite some time. The landlord wasn’t ready & willing to sell. They purchased the land from Slough Estates of the United Kingdom.
Taking ownership of the site would not necessarily allow Pfizer to operate any differently on the campus where their Doctors and researchers do a lot of work with cancer research.
